391
Views
0
CrossRef citations to date
0
Altmetric
Methodology

Synuclein-One Study: Skin Biopsy Detection of Phosphorylated α-Synuclein for Diagnosis of Synucleinopathies

ORCID Icon, , , , &
Pages 499-509 | Received 16 Aug 2021, Accepted 11 Feb 2022, Published online: 11 Mar 2022
 

Abstract

Finding an easily accessible and reliable tool to diagnose the diseases collectively defined as ‘synucleinopathies’ is an urgent, unmet priority. The synucleinopathies include Parkinson's disease, multiple system atrophy, pure autonomic failure and dementia with Lewy bodies. There are millions of people who have a diagnosis of a synucleinopathy, with more diagnosed every year. With accessibility, ease of implementation, consistently high sensitivity (>80%) and specificity approaching 100%, skin biopsy has great potential as the clinical test of choice for the diagnosis of synucleinopathies. The large, multi-center Synuclein-One study will determine the sensitivity, specificity, accuracy and precision of α-synuclein detection within punch skin biopsies in patients with clinically established synucleinopathies using standardized, robust methods suitable for large-scale analysis.

Clinical Trial Registration: NCT04700722 (ClinicalTrials.gov)

Financial & competing interests disclosure

The study is supported by NIH 5R44NS117214. CH Gibbons has received research support from Grifols, serves as a scientific advisor for CND Life Sciences and holds stock options in CND Life Sciences. R Freeman has served as a scientific advisor or received research support from Akcea, Biogen, CND Life Sciences and Vertex and holds stock options in CND Life Sciences. B Bellaire is employed by CND Life Sciences. T Levine has served as a scientific advisor for Grifols and FFF Enterprises and holds stock options in Corinthian Reference Lab and CND Life Sciences. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.

Ethical conduct of research

All study procedures are standardized and are carried out in compliance with local and central institutional review board approval.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.